Clinical Trials

Inclusion Criteria:

• Age 18 years and older
• Ability to comprehend the study procedures and agreement to proceed with primary SLT treatment
• Diagnosis of primary or secondary open angle glaucoma or glaucoma suspects with ocular hypertension
• Bilateral disease
• Pre-SLT IOP >21 mmHg measured at least twice during patient’s lifetime with or without medication
• Open angles with moderate to intense trabecular pigmentation
• Mild to moderate visual field defects (24-2 standard mean deviations better than the Swedish interactive thresholding algorithm standard of 12 dB)
• No adequate IOP control   (low treatment compliance, substantial adverse effects with eyedrops, and at least 2 IOP measurements higher than the individualized target IOP)

Exclusion Criteria: 

• Unwilling or unable to give consent
• Unable to attend scheduled post-operative visits
• Previous history of either laser treatment or intraocular surgery, except for non-complicated cataract surgery (performed >6 months before SLT)
• History of ocular trauma
• Narrow angles
• Retinal detachment
• Active iris neovascularization or active proliferative retinopathy
• Active uveitis
• Monocular patients
• Current use of steroids (ocular, periocular, or systemic)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/14/2024. Questions regarding updates should be directed to the study team contact.